Trial Profile
A Double Blind, Randomized Controlled Trial Examining the Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-abdominal Collections in Children - a Prospective Study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Abscess
- Focus Therapeutic Use
- 25 Jun 2019 Status changed from suspended to discontinued.
- 03 May 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2019.
- 03 May 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2019.